ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MYO vs MLSS // FORWARD P/E MULTIPLE

Myomo Inc. (NYSE) VS. Milestone Scientific Inc. (NYSE) • 15-METRIC TALLY: MYO 3 — MLSS 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MYO VS. MLSS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MYO MLSS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 65.70% 71.40% -5.70 MLSS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -10.27% — TIE /fcf-yield <GO>
Operating Margin -35.20% -60.00% +24.80 MYO /operating-margins <GO>
Net Profit Margin -38.10% 63.80% -101.90 MLSS /net-margins <GO>
Revenue Growth (YoY) 25.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.9 40.8 +7.10 MYO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 4.7x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $51.5M $28.6M $22.9M MYO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MYO REV MLSS REV MYO GROSS % MLSS GROSS % MYO FCF MLSS FCF
FY 2025 $40.9M $9.0M 65.7% 71.4% -$16.3M -$2.9M
FY 2024 $32.6M $8.6M 71.2% 74.6% -$4.7M -$2.9M
FY 2023 $19.2M $0 — — -$6.2M -$5.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MYO // BETA —
MLSS // BETA —